Related Experiment Video
Updated: Oct 3, 2025

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
Gut barrier disruption and chronic disease
Jan Martel1, Shih-Hsin Chang2, Yun-Fei Ko3
1Center for Molecular and Clinical Immunology, Chang Gung University, Taoyuan, Taiwan; Chang Gung Immunology Consortium, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
The gut barrier protects against harmful substances, but disruption can cause inflammation and disease. Emerging research suggests interventions targeting gut barrier integrity and microbiota may help treat metabolic, autoimmune, and aging-related disorders.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- The intestinal barrier is crucial for host defense against gut microbes, antigens, and toxins.
- Factors like diet, antibiotics, stress, and aging can compromise gut barrier integrity.
- Chronic disruption leads to microbial translocation and systemic inflammation.
Purpose of the Study:
- To review recent studies on the gut barrier's role beyond intestinal diseases.
- To explore the contribution of gut barrier dysfunction and microbiota dysbiosis to metabolic, autoimmune, and aging-related disorders.
- To describe emerging interventions for improving gut barrier function and microbiota composition.
Main Methods:
- Literature review of recent scientific studies.
- Analysis of the relationship between gut barrier integrity, microbiota dysbiosis, and systemic diseases.
- Identification and description of novel therapeutic strategies.
Main Results:
- Gut barrier dysfunction and microbiota dysbiosis are implicated in metabolic, autoimmune, and aging-related disorders.
- Systemic inflammation is a consequence of microbial translocation due to compromised gut barrier.
- Several interventions show promise in restoring gut barrier integrity and microbiota balance.
Conclusions:
- The gut barrier plays a significant role in systemic health, influencing metabolic, autoimmune, and aging processes.
- Maintaining gut barrier integrity and a balanced microbiota is essential for preventing and managing chronic diseases.
- Future research and therapeutic strategies should focus on gut barrier health and microbiota modulation.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Physiology of Enteric Nervous System and Gut Health
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

